
|Articles|July 7, 2014
Eurofins Central Laboratory Expands US Lab Operations to PA Campus
Eurofins Central Laboratory announced the expansion and relocation of its US Central Laboratory Operations to the company's Pharma Services campus in Lancaster, PA.
Advertisement
Eurofins Central Laboratory announced the expansion and relocation of its US Central Laboratory Operations to the company's 330,000 square foot Pharma Services campus in Lancaster, PA. The consolidation of the company's Central Laboratory with its Lancaster Laboratories comes amongst the recently announced acquisitions of US bioanalytical, discovery, genomic and diagnostic laboratories. The purpose built Central Laboratory is essential to the global footprint of wholly-owned laboratory facilities in the United States, Europe,Asia and China.
Read the full release
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
AI-Driven Clinical Trial Recruitment and Design
2
What Clinical Trials Can Learn from the Gig Economy About Payments
3
PLPS Launches MyClinicalSuite™ to Deliver Faster Clinical Trial Label Turnarounds Without Compromising Quality, Compliance, or Patient Safety
4
ACT Brief: RBQM Financial Value Quantified, Sponsor-Configurable AI Systems, and Basket Trials for Rare Pediatrics
5




